These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7459607)

  • 21. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
    Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
    Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Raynaud's phenomenon and blood viscosity].
    Lacombe C; Mouthon JM; Bucherer C; Lelievre JC; Bletry O; Godeau P
    J Mal Vasc; 1992; 17 Suppl B():132-5. PubMed ID: 1602250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Finger plethysmography for studying the blood rheological and hemodynamic components of an acrosyndrome].
    de Faucal P; Planchon B; Boudard D; Peltier P; Barrier J; Grolleau JY
    J Mal Vasc; 1986; 11(4):356-61. PubMed ID: 3805897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood flow changes with naftidrofuryl in systemic sclerosis and Raynaud's phenomenon.
    Gaylarde PM; Tan OT; Sarkany I
    Br J Dermatol; 1980 Jan; 102(1):7-10. PubMed ID: 7378283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon.
    Gastaud M; Dolisi C; Bermon S; Gaudin P; Defauw G; Ardisson JL
    Clin Exp Rheumatol; 1995; 13(5):617-21. PubMed ID: 8575140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postocclusive reactive hyperemia in hand-arm vibration syndrome.
    Stoyneva Z
    Int J Occup Med Environ Health; 2016; 29(4):659-66. PubMed ID: 27443761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of the Raynaud's phenomenon with piracetam.
    Moriau M; Lavenne-Pardonge E; Crasborn L; von Frenckell R; Col-Debeys C
    Arzneimittelforschung; 1993 May; 43(5):526-35. PubMed ID: 8328997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemorheological factors in Raynaud's phenomenon.
    Dintenfass L
    Angiology; 1977 Jul; 28(7):472-81. PubMed ID: 900567
    [No Abstract]   [Full Text] [Related]  

  • 30. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiological classification of Raynaud's phenomenon.
    Nilsen KH
    Br J Dermatol; 1980 Jan; 102(1):1-5. PubMed ID: 7378276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does prevalence of migraine and Raynaud's phenomenon also increase in Korean patients with proven variant angina?
    Koh KK; Kim SH; Lee KH; Kwon KS; Kim EJ; Baik SH; Cho SK; Kim SS; Park CO; Chung JK
    Int J Cardiol; 1995 Aug; 51(1):37-46. PubMed ID: 8522395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte transport efficacy of human blood: a rheological point of view.
    Bogar L; Juricskay I; Kesmarky G; Kenyeres P; Toth K
    Eur J Clin Invest; 2005 Nov; 35(11):687-90. PubMed ID: 16269018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
    Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
    BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raynaud's phenomenon.
    Wigley FM; Flavahan NA
    Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ketanserin on peripheral blood flow, haemorheology, and platelet function in patients with Raynaud's phenomenon.
    Longstaff J; Gush R; Williams EH; Jayson MI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S99-101. PubMed ID: 2412071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomenclature of Raynaud's phenomenon: a capillary microscopic and hemorheologic study.
    Jacobs MJ; Breslau PJ; Slaaf DW; Reneman RS; Lemmens JA
    Surgery; 1987 Feb; 101(2):136-45. PubMed ID: 3810484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis.
    Lau CS; McLaren M; Saniabadi A; Belch JJ
    Scand J Rheumatol; 1993; 22(3):97-101. PubMed ID: 8316776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered microrheological parameters in Raynaud's phenomenon.
    Papp J; Sandor B; Toth A; Biro K; Rabai M; Botor D; Kovacs D; Csernus Z; Toth K; Kesmarky G
    Clin Hemorheol Microcirc; 2017; 65(1):23-29. PubMed ID: 27258205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.